MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN PEDIATRIC PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Registry ID

MSP-2017-1265 (NODE-202)

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

MILESTONE PHARMACEUTICALS INC

Start date

2025-02-14

Last update

2024-02-08

Conditions

• PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)

Related clinical trials

• MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY, AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR THE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

View on source registry